- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
GPS driving: a digital biomarker for preclinical Alzheimer disease ; volume:13 ; number:1 ; day:14 ; month:6 ; year:2021 ; pages:1-9 ; date:12.2021
Alzheimer's research & therapy ; 13, Heft 1 (14.6.2021), 1-9, 12.2021
- Creator
-
Bayat, Sayeh
Babulal, Ganesh M.
Schindler, Suzanne E.
Fagan, Anne M.
Morris, John C.
Mihailidis, Alex
Roe, Catherine M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-021-00852-1
- URN
-
urn:nbn:de:101:1-2021100421451159296260
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bayat, Sayeh
- Babulal, Ganesh M.
- Schindler, Suzanne E.
- Fagan, Anne M.
- Morris, John C.
- Mihailidis, Alex
- Roe, Catherine M.
- SpringerLink (Online service)
Other Objects (12)
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward
Developing preclinical models of neuroblastoma: driving therapeutic testing
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
APP mouse models for Alzheimer's disease preclinical studies
Preclinical Alzheimer’s dementia: a useful concept or another dead end?
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Possibilities of high precision GPS data in autonomous driving
Neue multimodale Biomarker der Alzheimer-Erkrankung
Amyloid blood biomarker detects Alzheimer's disease
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward
Developing preclinical models of neuroblastoma: driving therapeutic testing
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
APP mouse models for Alzheimer's disease preclinical studies
Preclinical Alzheimer’s dementia: a useful concept or another dead end?
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Possibilities of high precision GPS data in autonomous driving
Neue multimodale Biomarker der Alzheimer-Erkrankung
Amyloid blood biomarker detects Alzheimer's disease
P‐tau235: a novel biomarker for staging preclinical Alzheimer’s disease
Driving assessment in preclinical Alzheimer’s disease: progress to date and the path forward
Developing preclinical models of neuroblastoma: driving therapeutic testing
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
APP mouse models for Alzheimer's disease preclinical studies
Preclinical Alzheimer’s dementia: a useful concept or another dead end?
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Possibilities of high precision GPS data in autonomous driving
Neue multimodale Biomarker der Alzheimer-Erkrankung